Objective: To evaluate intensive care-related factors as predictors of depressive symptoms 6 months after acute lung injury (ALI).
S urvivors of acute lung injury (ALI) experience substantial long-term morbidity, including impairments in quality of life (1, 2) and neuromuscular (3, 4) , cognitive (5) , and psychologic (6, 7) function. Depression seems particularly common, with a point prevalence of clinically significant depressive symptoms ranging from 17% to 43% at 12-24 months after ALI (6) . Previous studies of intensive care unit (ICU) survivors have demonstrated that factors related to patient recovery, including longer time since ALI (8) and improved post-ICU physical functioning (9) , are associated with fewer depressive symptoms. However, little is known about how features of critical illness and ICU care themselves relate to post-ALI depression (6, 10) . Thus, we measured symptoms of depression at 6 months after ALI and evaluated associations of those symptoms with 12 intensive care-related factors measured prospectively in the ICU.
MATERIALS AND METHODS
Study Population. Consecutive mechanically ventilated patients with ALI were enrolled in a prospective cohort study conducted in 13 ICUs at four hospitals in Baltimore, MD (11) . To avoid inclusion of patients with primary neurologic disease or trauma, neurologic specialty ICUs at the participating hospitals were not included. Key exclusion criteria were 1) preexisting illness with a life expectancy of Ͻ6 months; 2) preexisting cognitive impairment or communication/language barrier; 3) transfer into a study site ICU with preexisting ALI of Ͼ24 hours duration; 4) Ͼ5 days of mechanical ventilation before ALI; 5) no fixed address; and 6) patient or family requests for no escalation of care, such as no vasopressors or no hemodialysis.
Measurement of Baseline and ICU-Related Exposures. Patient demographics and the Acute Physiology and Chronic Health Evaluation II severity of illness score (12) were obtained on admission to the study site ICU. The Sequential Organ Failure Assessment Score (13) , minimum blood glucose, and the dose, route, and frequency of administration of selected medications (corticosteroids, narcotics, and benzodiazepines) were collected daily after ALI diagnosis while patients were in the ICU. Patients' prehospitalization functional status (independence in activities of daily living ͓14͔), years of formal education, and employment status were collected by interview with the patient (or proxy, when unable to obtain patient response). Mood symptoms before the onset of the illness that necessitated hospital admission were assessed by retrospective patient interview using the depression/ anxiety dimension of the EQ-5D quality of life instrument (15) . In the current analysis, a response of "moderate" or "extreme" depres-sion/anxiety (vs. "none") was considered positive for abnormal baseline mood. All potential risk factors measured on a continuous scale were modeled as tertiles using clinically relevant thresholds closest to the 33rd and 67th percentile to characterize nonlinear associations and prevent undue influence from outlying observations.
Measurement of Depressive Symptoms After Discharge. The outcome of interest was depressive symptoms at 6 months after ALI diagnosis, measured using the depression subscale of the Hospital Anxiety and Depression (HAD) instrument (16) . The HAD instrument contains two seven-item subscales that separately measure symptoms of depression and anxiety. These subscales define separable symptom complexes based on factor analysis of this instrument (17) . The depression subscale of the HAD instrument was specifically designed to screen for depression in medically ill patients, primarily measuring anhedonia rather than the "physical" symptoms of depression (e.g., loss of appetite) that frequently occur in conjunction with physical illness. We did not evaluate the HAD anxiety subscale because the symptoms it measures do not closely correspond to a specific psychiatric syndrome and have not been clearly linked to ICU-related factors in ALI survivors (6) .
The HAD depression subscale score ranges from 0 to 21, with a higher score indicating greater depressive symptoms. A score of 8 -10 indicates "possible depression" and Ն11 indicates "likely clinical depression" (16) . In the primary analysis, we modeled the depression subscale score as a continuous variable. In a secondary analysis, we used a binary measure of depression, defined a priori using the standard cutoff threshold of Ն8. Although the HAD is a validated instrument, it does not permit a clinical diagnosis of depression, which requires a clinical psychiatric interview. Consequently, we refer to the outcome measure as "depressive symptoms," rather than "depression."
Statistical Analysis. We compared the distribution of all baseline and ICU-related exposure variables by depression screening status (HAD depression subscale Ͻ8 vs. Ն8) using Fisher's exact test (categorical variables) and Student's t test (continuous variables) ( Table  1 ). For each of these exposure variables, we calculated the univariable p value for its association with the mean depression score using linear regression, and for its association with a positive depression screening test (HAD depression subscale score Ն8) using Fisher's exact test or logistic regression, as appropriate. All exposure variables having a crude association with depressive symptoms (p Յ 0.15) were analyzed in multivariable linear (mean depression score) or logistic (positive depression screening) models. All significance tests were two sided, with statistical significance defined as p Ͻ 0.05.
For the binary outcome measure (depression subscale score Ն8), we calculated relative risks using log-binomial regression models. When the log-binomial model failed to converge, a Poisson regression model with robust variance calculation was used (18) . Missing data (which was limited to only education level, pre-ICU functional status, and pre-ICU depression/anxiety) were imputed using mean imputation based on a best-subset regression model using all other variables to model the missing data (19) . Influence was evaluated using added-variable plots. The effect of outlier data values on regression coefficients was estimated using Dfbeta statistics, and collinearity was assessed using variance inflation factors (19, 20) . Goodness of fit was evaluated using deviance residuals (21) . All analyses were performed using STATA version 9.2 (Stata, College Station, TX).
This study was approved by the institutional review boards of all participating institutions.
RESULTS
Of 520 patients enrolled in the cohort study, 284 (55%) survived to hospital discharge. Of these survivors, 50 (18%) died before consent or 6-month follow-up, 36 (13%) declined participation in longterm follow-up, and 14 (5%) were lost to follow-up, leaving 184 survivors at 6-month follow-up ( Fig. 1) . A total of 174 (95%) 6-month survivors were available for follow-up assessment, of whom 160 (92%) were able to complete the entire HAD questionnaire. The median (interquartile range) HAD depression subscale score was 5 (2-8) and the mean (SD) was 5.2 (4.2). The prevalence of a positive screening test for depression (score Ն8) was 26% (41/160) ( Table 1 ). Using a more stringent threshold (HAD depression subscale score Ն11), the prevalence of a positive depression screen was 11% (18/160).
Three ICU-related factors were significantly associated with depressive symptoms, whether measured as a continuous score ( Table 2) or dichotomized as a positive screening test for depression (Table  3) . Patients admitted to a surgical (vs. medical or trauma) ICU had an increase in mean HAD score of 2.7 points (95% confidence interval ͓CI͔ 0.8 -4.5), and a relative risk for a positive depression screening test of 2.2 (95% CI 1.1-4.2). Similarly, patients receiving a mean daily benzodiazepine dose of Ն75 mg of midazolam equivalent had a mean HAD increase of 2.0 points (95% CI 0.6 -3.5), and those with a maximum organ dysfunction (Sequential Organ Failure Assessment) score of Ͼ10 had an increase of 1.6 points (95% CI 0.2-3.0). Both of these latter factors were associated with a relative risk for a positive depression screening test of 2.1 (95% CI 1.2-3.5). Patients admitted to surgical ICUs (vs. medical or trauma ICUs) had a lower median (interquartile range) daily benzodiazepine dose (midazolam-equivalent dose: 3.4 ͓0.9 -32.0͔ vs. 38.5 ͓15.8 -94.2͔ mg, p Ͻ 0.001) and a similar median (interquartile range) value for maximum Sequential Organ Failure Assessment Score (9 ͓8 -11͔ vs. 9 ͓7-11͔; p Ͼ 0.9).
None of the baseline patient characteristics evaluated in this analysis were significantly associated with both mean depression score and positive screening results. However, patients with education Յ12 years had significantly higher mean HAD scores than patients with more education (1.7 points; 95% CI 0.3-3.0), and preadmission depression/anxiety was significantly associated with a positive screening test (relative risk 2.0; 95% CI 1.1-3.6).
Two ICU-related factors were associated with mean HAD depression subscale score (p Ͻ 0.15) in univariable analysis but excluded from further analyses due to collinearity with ICU length of stay: duration of mechanical ventilation Ͼ7 days (univariable increase of 1.1 points; 95% CI Ϫ2.5 to 0.3; p ϭ 0.12) and tracheotomy (increase of 1.2 points; 95% CI Ϫ0.4 to 2.7; p ϭ 0.13). Separately including these variables in the multivariable model revealed that neither variable was significantly associated with the mean HAD depression subscale score (p Ͼ 0.2 for each), and neither variable materially changed the other multivariable results. The maximum variance inflation factor in the final multivariable model ( Table 2) was 1.28, suggesting little collinearity.
DISCUSSION
This prospective analysis of 160 ALI survivors demonstrates that depressive symptoms at 6 months after ALI are both common and potentially associated with features of critical illness and intensive care. In this research, representing the largest published study of long-term psychiatric morbidity in ALI survivors to date, the factors most consistently associated with depressive symptoms included admission to a surgical (vs. medical or trauma) ICU, maximum organ dysfunction score, and higher mean daily benzodiazepine dose in the ICU.
The 26% prevalence of a positive depression screening test at 6 months after ALI in this study is similar to the 28% (14) . Proxy response was used when patients could not respond; f per EQ-5D quality of life survey (15) administered retrospectively to patients after ICU discharge; g severity of illness score ranging from 0 (best) to 71 (worst) based on physiologic variables within 24 hrs of ICU admission, age, and chronic comorbidities (12) ; h organ dysfunction score, recorded daily in the ICU, ranging from 0 (best) to 24 (worst) based on six major organ systems (13) .
prevalence observed earlier in our cohort at 3-month follow-up (22) and the 25% to 32% rates reported in other populations of mechanically ventilated patients at 6 -12 months after discharge (23) (24) (25) . This prevalence is substantially higher than the 8% prevalence of a positive depression screening test (using HAD depression subscale score Ն8) in a general adult population (26) and further confirms the high burden of psychiatric morbidity in ALI survivors. Among the 12 characteristics we examined in the ICU, three (admission to surgical ICU, maximum organ dysfunction, and benzodiazepine dose) were significantly associated with depressive symptoms, when measured as both a continuous score and as a binary outcome (positive screening test). However, given the relatively small body of literature in this field, we caution that these associations are exploratory in nature. Regarding ICU type, specifically, we caution that only 14% of our cohort was admitted to a surgical ICU, thus, limiting our ability to compare surgical vs. medical ICUs. Furthermore, to avoid overlooking associations of potential clinical importance, we did not adjust for multiple comparisons; hence, statistical chance may play a role in our findings.
Using a subset of the present cohort (n ϭ 104, 65% of the present sample), we previously investigated the association of ICU hypoglycemia with depressive symptoms at 3 months post-ALI. This variable had a significant association, as did two patient baseline factors (preadmission anxiety/depression and morbid obesity) and, to a lesser extent, one other ICUrelated factor (higher daily benzodiazepine dose) (22) . These associations with depressive symptoms at 3 months were all reconfirmed using the full cohort analyzed in this study (data not shown). Of these four factors, only benzodiazepine dose remained significantly associated with depressive symptoms at 6 months post-ALI. In addition, two new ICUrelated factors-admission to a surgical ICU and maximum ICU organ dysfunction score-were also significantly associated with depressive symptoms at 6 months. These differences in findings at 3 vs. 6 months suggest that post-ALI depressive symptoms may follow a dynamic course; notably, only 61% of patients with a positive depression screening test at 6 months had a positive screen at 3 months. These differences may also reflect statistical chance; alternatively, sur- a Measured by the seven-item HAD instrument's depression subscale, a continuous measure ranging from 0 to 21 with predefined thresholds for depression screening of Ն8 and Ն11 (16) . Results are presented as the increase in mean HAD depression subscale score, comparing patients with the factor of interest to those without that factor, using a linear regression model; b the values of p calculated using linear least-squares regression. Where two contiguous tertiles did not differ in their mean HAD depression subscale score (p Ͼ 0.15), they were combined to create a binary variable. All factors with a univariable p value Ͻ0.15 are included; c per EQ-5D quality of life survey (15) administered retrospectively to patients after ICU discharge; d six items describing pre-ICU functional status: bathing, dressing, toileting, transferring, continence, and feeding (14) . Proxy response was used when patients could not respond; e this organ dysfunction score is recorded daily in the ICU and ranges from 0 (best) to 24 (worst) based on six major organ systems (13) . gical issues or severity of illness during intensive care may result in lasting physical morbidity that influences psychopathology more in the medium term than shortly after hospital discharge.
Previous studies have suggested that post-ICU depression is associated with pre-ICU functional status (8) and duration of ICU stay or sedative administration (27) . In univariable analyses, we found similar associations of all three variables with mean HAD score. However, the effects of these variables were markedly attenuated in our multivariable models, which adjusted for other covariates not included in the original studies (adjusted p ϭ 0.59 for duration of benzodiazepines; other variables in Table 2 ). Although we did find a significant association between depressive symptoms and mean benzodiazepine dose, this relationship may not be causal; rather, it may reflect that patient distress in the ICU (prompting more sedation) identifies individuals who are more likely to be distressed in general (28) . Our study also differs in methodology from previous studies. Weinert and Meller (8) evaluated patients with acute respiratory failure rather than ALI and combined results from 2-month and 6-month follow-up into a single analysis. Nelson et al (27) used a retrospective questionnaire format administered to 24 patients at 6 -41 months after ALI and evaluated the duration of any sedative use, evaluating both benzodiazepines and narcotics together.
These differences in study design may provide additional explanation for the differences noted when comparing our results with these previous studies.
This research has a number of potential limitations. First, we measured depressive symptoms at follow-up with the seven-item HAD depression subscale. Although this screening instrument has been validated in medically ill patients and has been used in Ͼ700 studies (17), including numerous studies of ICU survivors (29 -31) , a positive screening test does not represent a clinical diagnosis of depression. In addition, the HAD instrument does not include measures of physical symptoms, guilt, worthlessness, or suicidality, and although its sensitivity for clinical depression is high (17) , it may miss depressed patients in whom anhedonia is not prominent. Future studies using clinical interviews of ICU survivors would be useful in this regard. Second, we limited our study to depressive symptoms and cannot comment on associations with other potentially important psychiatric outcomes, such as posttraumatic stress (6, 32, 33) . Third, we did not collect detailed data on prior psychiatric history or post-ALI psychiatric treatment (e.g., psychotherapy and antidepressants), which might reduce the burden of depressive symptoms in patients who would otherwise meet clinical criteria for depression (8) . Fourth, 18% of hospital survivors died within 6 months of ALI, and an additional 13% declined participa-tion in this longitudinal study. Although losses to follow-up in this study were less than in prior longitudinal cohorts of acute respiratory distress syndrome survivors (3, 23) , our results may not generalize to all ALI survivors.
CONCLUSIONS
This prospective analysis of 160 ALI survivors demonstrates that depressive symptoms are common at 6 months after ALI and seem to be associated with aspects of critical illness and intensive care management. Future studies should continue to investigate intensive carerelated factors, as well as the effect of premorbid psychopathology and post-ICU factors arising during patients' recovery, to better understand the mechanisms by which patients develop long-term psychiatric morbidity after critical illness.
